Decision: Favourable

Decisions Table

Study Title:

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients with Amyotrophic Lateral Sclerosis (DAZALS)

  • NREC Code:

    23-NREC-CT-034

  • Decision:

    Favourable

  • Meeting Date:

    24/03/2023

  • Study Type:

    CT application

  • Principal Investigator:

    Prof Orla Hardiman

  • PI Institution:

    Beaumont Hospital

  • Sponsor:

    Corcept Therapeutics

Scroll to Top